Wednesday, July 6, 2022

Eurofins Discovery Acquires DiscoveryBioMed

San Diego-based Eurofins Discovery, a provider of in vitro safety and pharmacology assays and panels for drug screening and profiling, says it has acquired DiscoveryBioMed, a contract research organization (CRO). Eurofins Discovery said DiscoveryBioMed is developing novel human bioassays utilizing cells from diseased and normal human tissues. Financial details of the deal were not announced. DiscoveryBioMed was headquartered in Birmingham, Alabama.